KR20250099473A - Cosmetic composition for improving skin itching comprising the complex extract of sophora japonica fruits, dried ginger and akebiae quinata caulis, and manufacturing method thereof - Google Patents
Cosmetic composition for improving skin itching comprising the complex extract of sophora japonica fruits, dried ginger and akebiae quinata caulis, and manufacturing method thereof Download PDFInfo
- Publication number
- KR20250099473A KR20250099473A KR1020230189108A KR20230189108A KR20250099473A KR 20250099473 A KR20250099473 A KR 20250099473A KR 1020230189108 A KR1020230189108 A KR 1020230189108A KR 20230189108 A KR20230189108 A KR 20230189108A KR 20250099473 A KR20250099473 A KR 20250099473A
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- extract
- complex extract
- paragraph
- itching
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/608—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 회화나무열매, 건강 및 으름덩굴줄기의 복합추출물을 유효성분으로 포함하는 가려움 개선용 화장료 조성물 및 그 제조방법 에 관한 것으로, 본 발명으로부터 제공되는 회화나무열매, 건강 및 으름덩굴줄기의 복합추출물을 유효성분으로 포함하는 나노 리포좀(SOPHONLC)은 회화나무열매, 건강 및 으름덩굴줄기의 복합추출물을 사용하는 것에 비해 가려움 개선 효능, 피부보습 효능이 우수하기 때문에, 이를 유효 성분으로 한 화장료 조성물 등으로 유용하게 활용될 수 있다. The present invention relates to a cosmetic composition for improving itching comprising a composite extract of Phellodendron amurense, Ginseng and Gosling stems as active ingredients, and a method for producing the same. The nano liposome (SOPHONLC) comprising a composite extract of Phellodendron amurense, Ginseng and Gosling stems as active ingredients provided by the present invention is superior in anti-itching and skin moisturizing efficacy compared to the use of a composite extract of Phellodendron amurense, Ginseng and Gosling stems, and therefore can be usefully utilized as a cosmetic composition or the like using the same as an active ingredient.
Description
본 발명은 가려움 개선용 화장료 조성물 또는 이의 제조방법에 관한 것으로, 더욱 상세하게는 나노지질담체(Nanastructured Lipid Carrier) 공법을 이용하여 나노 리포좀으로 제조된 회화나무열매, 건강 및 으름덩굴줄기의 복합추출물을 유효성분으로 포함하여 피부 보습, 가려움 개선 완화 효과를 갖는 화장료 조성물 및 그 제조방법에 관한 것이다.The present invention relates to a cosmetic composition for improving itching or a method for producing the same, and more specifically, to a cosmetic composition having skin moisturizing and itching alleviating effects and a method for producing the same, which comprises a composite extract of the fruit of the locust tree, health, and the stem of the quince, manufactured as a nanoliposome using a nanostructured lipid carrier method, as an effective ingredient.
전 세계적으로 미세먼지는 매우 심각한 단계에 있으며, 이런 미세먼지는 현대인들에게 호흡기 질환 뿐만 아니라 접촉성 피부염이나 습진 등 여러 형태의 피부질환을 유발하는 등 심각한 피해를 나타내고 있다.Fine dust is at a very serious level worldwide, and this fine dust causes serious damage to modern people, such as respiratory diseases as well as various skin diseases such as contact dermatitis and eczema.
이에 민감성 피부관련 트러블 진정완화 제품 시장규모는 화장품 산업의 꾸준한 성장과 더불어 매년 15% 이상 꾸준히 성장하고 있다.Accordingly, the market size of products for calming and relieving sensitive skin-related troubles is growing steadily by more than 15% every year along with the steady growth of the cosmetics industry.
또한, 최근 여러 화학 물질 등에 의한 피부 자극을 줄이기 위해 천연물을 사용한 화장품이 많이 개발되고 있다. 천연 재료는 피부에 부작용이 적을 뿐만 아니라, 최근 천연 재료를 이용한 화장품에 대한 소비자들의 호응이 높아짐에 따라 화장품 원료로서 개발 가치가 한층 늘어나고 있기 때문이다.In addition, many cosmetics using natural materials are being developed recently to reduce skin irritation caused by various chemicals. Natural materials not only have fewer side effects on the skin, but as consumers' response to cosmetics using natural materials has increased recently, their development value as cosmetic raw materials is increasing even more.
회화나무열매는 콩과에 속하는 낙엽활엽교목인 회화나무(Sophora japonica)의 열매로서, 회화나무의 꽃과 열매는 한방에서 한약재로 사용되며, 콩잎에서 분리한 플라보노이드 화합물인 apigenin과 isoflavone류의 성분을 함유하고 있어 항염, 지혈, 고혈압, 치질, 습진 치료 등에 효과를 보이고 있으며, 장출혈, 자궁출혈, 잇몸염증과 피부 화장 등에도 사용된다고 보고 되었다(송행선 등, 대한화장품학회,2016, 42(4), p351-358).Sophora japonica fruit is the fruit of Sophora japonica, a deciduous broad-leaved tree in the legume family. The flowers and fruit of Sophora japonica are used as herbal medicine in oriental medicine. It contains apigenin, a flavonoid compound isolated from soybean leaves, and isoflavones, and has been reported to have anti-inflammation, hemostatic, hypertension, hemorrhoids, and eczema treatment effects. It has also been reported to be used for intestinal bleeding, uterine bleeding, gum inflammation, and skin cosmetics (Song Haeng-seon et al., The Society of Cosmetic Scientists of Korea, 2016, 42(4), p351-358).
또한, 종래에는 회화나무 꽃, 열매, 가지 추출물의 효능과 효과를 알아보기 위해 메탄올이나 에탄올 환류 추출법 등이 이용되었다. 메탄올 회화나무 꽃 추출물의 폴리페놀 함량은 38.9 mg/g임에 비해 75% 에탄올 환류 추출법에 의해 추출된 회화나무 꽃 추출물의 폴리페놀 함량은 평균 261.38± 7.02 mg/g으로 보다 좋은 결과가 나타남을 볼 수 있다. 이러한 결과는 용매와 추출법 등에 성분의 효과에 영향을 준다고 볼 수 있다.(회화나무 꽃, 열매, 가지 추출물의 피부개선 효과에 관한 연구. 저자 송행선,장혜인.대한화장품학회 2016년 11월 10일)In addition, methanol or ethanol reflux extraction methods were used to determine the efficacy and effect of the extracts of the flowers, fruits, and branches of the Prunella vulgaris. The polyphenol content of the methanol Prunella vulgaris flower extract was 38.9 mg/g, while the polyphenol content of the Prunella vulgaris flower extract extracted by the 75% ethanol reflux extraction method was 261.38±7.02 mg/g on average, showing a better result. These results suggest that the solvent and extraction method affect the effect of the ingredients. (Study on the skin improvement effect of the extracts of the flowers, fruits, and branches of the Prunella vulgaris. Authors: Song Haeng-seon, Jang Hye-in. The Society of Cosmetic Scientists of Korea, November 10, 2016)
또한, 공개특허 제10-2011-0004603호에 적시된 바와 같이, 회화나무의 열매 추출물이 에스트로겐 중 가장 효능이 뛰어난 것으로 알려진 에스트라디올보다 에스트로겐 분비 활성이 더욱 좋은 것이 밝혀지면서 회화나무 추출물을 유효성분으로 포함하는 조성물의 연구가 활발히 진행되고 있다.In addition, as stated in Patent Publication No. 10-2011-0004603, since it was discovered that the extract of the fruit of the Chinese juniper tree has better estrogen secretion activity than estradiol, which is known to be the most effective among estrogens, research on compositions containing the extract of the Chinese juniper tree as an active ingredient is actively being conducted.
하지만 종래에 사용되고 있는 항노화, 피부주름개선에 효과있는 회화나무 추출물은 아스코르브산, 레티놀 및 콜라게나제활성을 단순히 억제하는 물질로 화장료나 의약품에 배합함으로써 피부의 주름 개선 및 노화를 방지하는 방법으로 이용되어 왔는데, 배합 시 안정성이 좋지 못하거나 피부 흡수가 용이하지 않아 그 효과가 미미하여 실질적인 효과를 얻기가 어려운 문제점이 있었다.However, the extract of the Chinese juniper tree, which has been used in the past for its anti-aging and wrinkle-improving effects, has been used as a method of improving wrinkles and preventing aging by mixing it with cosmetics or medicines as a simple substance that inhibits ascorbic acid, retinol, and collagenase activity. However, there was a problem that it was difficult to obtain a practical effect because the stability was poor when mixed or the skin did not absorb it easily, so the effect was minimal.
말린 생강인 건강은 항균, 항산화 효과 등의 생리활성이 알려져 있다.Dried ginger is known to have physiological activities such as antibacterial and antioxidant effects.
으름덩굴(Akebia quinata)은 으름 또는 어름나무라고도 불리며, 산과 들에서 자라며 길이는 약 5m이다. 한방에서는 뿌리와 줄기가 소염, 이뇨, 통경 작용에 효능이 있으므로 약재로 쓴다. 으름덩굴 추출물은 으름덩굴의 다양한 기관 또는 부분(예: 잎, 뿌리, 줄기, 가지, 여린가지, 껍질 및 종자 등)으로부터 추출하여 얻을 수 있다.Akebia quinata, also called Akebia or Akebia quinata, grows in mountains and fields and grows to about 5 m in length. In oriental medicine, the roots and stems are used as medicine because they are effective in anti-inflammatory, diuretic, and laxative effects. Akebia extract can be obtained by extracting various organs or parts of Akebia (e.g., leaves, roots, stems, branches, twigs, bark, and seeds).
본 발명의 목적은 피부 가려움 개선에 도움을 주는 효과를 가지면서 인체 부작용이 적고, 피부 흡수율이 높은 화장료 조성물 및 그 제조 방법을 제공하고자 하는 것이다.The purpose of the present invention is to provide a cosmetic composition that has an effect of helping to improve skin itchiness, has few side effects on the human body, and has a high skin absorption rate, and a method for producing the same.
또한, 본 발명의 목적은 나노지질담체(Nanastructured Lipid Carrier) 공법을 이용하여 나노 리포좀으로 제조된 회화나무열매, 건강 및 으름덩굴줄기의 복합추출물을 유효성분으로 하여 피부보습, 피부 가려움 개선에 도움을 주는 화장료 조성물 및 그 제조 방법을 제공하고자 하는 것이다.In addition, the purpose of the present invention is to provide a cosmetic composition that helps improve skin moisturization and skin itchiness by using a nanostructured lipid carrier method and a method for manufacturing the same, which contains a composite extract of the fruit of the locust tree, health, and the stem of the quince, as an effective ingredient.
상기 목적을 달성하기 위하여, 본 발명에 따른 가려움 개선용 화장료 조성물은, In order to achieve the above purpose, the cosmetic composition for improving itching according to the present invention,
회화나무열매, 건강 및 으름덩굴줄기를 혼합하여 추출한 복합추출물을 포함하되, 상기 복합추출물은 나노 리포좀으로 제조되어 함유되는 것을 특징으로 한다.A compound extract comprising a mixture of the fruits of the conversation tree, health and the stem of the vine, wherein the compound extract is manufactured and contained in the form of a nano liposome.
여기서, 상기 복합추출물의 회화나무열매, 건강 및 으름덩굴줄기는 5~10 : 0.5~1 : 0.5~1의 중량비로 혼합되는 것을 특징으로 한다.Here, the compound extract of the conversation tree fruit, health, and mugwort stem is characterized in that it is mixed in a weight ratio of 5 to 10: 0.5 to 1: 0.5 to 1.
또한, 본 발명의 가려움 개선용 화장료 조성물에서,In addition, in the cosmetic composition for improving itching of the present invention,
상기 복합추출물은 소포리코시드(Sophoricoside)를 함유하는 것을 특징으로 한다.The above complex extract is characterized by containing sophoricoside.
또한, 본 발명에 따른 가려움 개선용 화장료 조성물 제조방법은,In addition, the method for producing a cosmetic composition for improving itching according to the present invention,
회화나무열매, 건강 및 으름덩굴줄기를 혼합하여 혼합물을 제조하는 제1 단계;Step 1: Making a mixture by mixing the fruits of the conversation tree, health and the vine;
상기 제1 단계의 혼합물을 에탄올로 추출하는 제2 단계;A second step of extracting the mixture of the first step with ethanol;
상기 제2 단계의 추출 진행 후 냉각하여 감압농축을 통해 복합추출물을 얻는 제3 단계; 및A third step of obtaining a complex extract through cooling and depressurization concentration after the extraction in the second step; and
상기 제3 단계로 얻은 복합추출물을 숙성시키는 제4 단계;를 포함하여 제조된 복합추출물을 함유하며,A fourth step of maturing the complex extract obtained in the third step; containing the manufactured complex extract,
상기 제조된 복합추출물을 고체지질과 액체지질, 및 유화보조제와 함께 고압미세유화기를 통과시켜 나노 리포좀으로 제조하는 것을 특징으로 한다.The invention is characterized in that the above-mentioned manufactured complex extract is passed through a high-pressure microemulsifier together with solid lipids, liquid lipids, and an emulsifying agent to produce nano liposomes.
이때, 상기 제1 단계의 복합추출물의 회화나무열매, 건강 및 으름덩굴줄기는 5~10 : 0.5~1 : 0.5~1의 중량비로 혼합될 수 있다.At this time, the conversation tree fruit, health and mugwort stem of the compound extract of the first step can be mixed in a weight ratio of 5 to 10: 0.5 to 1: 0.5 to 1.
또한, 상기 제1 단계에는 보습제와 방부제가 포함되고,Additionally, the first step includes a moisturizer and a preservative,
상기 보습제는 다이프로필렌글라이콜, 상기 방부제는 1,2-헥산다이올이 포함될 수 있다.The above moisturizer may include dipropylene glycol, and the above preservative may include 1,2-hexanediol.
또한, 본 발명에 따른 가려움 개선용 화장료 조성물 제조방법에서,In addition, in the method for manufacturing a cosmetic composition for improving itching according to the present invention,
상기 제조된 복합추출물은 복합추출물은 소포리코시드(Sophoricoside)를 함유하는 것을 특징으로 한다.The above-mentioned manufactured complex extract is characterized in that it contains sophoricoside.
또한, 상기 고체지질은 하이드로제네이티드레시틴, 세틸팔미테이트로 이루어진 군에서 선택된 1이상이며, 상기 액체지질은 마카다미아씨오일이고,In addition, the solid lipid is at least one selected from the group consisting of hydrogenated lecithin and cetyl palmitate, and the liquid lipid is macadamia seed oil.
상기 유화보조제는 폴리글리세릴-3메틸글루코오스다이스테아레이트인 것을 특징으로 한다.The above emulsifying agent is characterized by being polyglyceryl-3 methyl glucose distearate.
또한, 본 발명에 따른 가려움 개선용 화장료 조성물 제조방법에서,In addition, in the method for manufacturing a cosmetic composition for improving itching according to the present invention,
상기 복합추출물은 화장료 조성물 총 중량 대비 30~35 중량% 함유되는 것을 특징으로 한다.The above complex extract is characterized in that it is contained in an amount of 30 to 35 wt% based on the total weight of the cosmetic composition.
본 발명에 의하여 제공되는 화장료 조성물은 회화나무열매, 건강 및 으름덩굴줄기의 복합추출물을 유효성분으로 포함하는 나노지질담체(Nanastructured Lipid Carrier) 공법을 이용한 나노 리포좀이 안정도 및 분산성을 향상시키고 피부 흡수율을 높이는 효과를 갖고 있다. The cosmetic composition provided by the present invention has the effect of improving stability and dispersibility and increasing skin absorption rate by using a nano-liposome method using a nanostructured lipid carrier containing a composite extract of the fruit of the Chinese juniper tree, health, and the stem of the Chinese juniper tree as effective ingredients.
또한, 나노 리포좀을 포함한 화장료 조성물은 피부 보호 및 피부 가려움 개선에 도움을 주는 화장료 조성물 또는 피부 외용제로 제조될 수 있다. Additionally, a cosmetic composition including nano liposomes can be manufactured into a cosmetic composition or skin external application that helps protect the skin and improve skin itchiness.
도 1은 본 발명에 따른 Sophoricoside를 함유하는 복합추출물의 나노 리포좀의 입자 직경 크기를 Photal ELS-Z 를 사용하여 측정한 결과이다.
도 2는 본 발명에 따른 Sophoricoside를 함유하는 복합추출물의 나노 리포좀의 안정성 측정을 위해 제타포텐셜을 Photal , ELS-Z 를 이용하여 측정한 결과이다.
도 3은 본 발명에 따른 Sophoricoside를 함유하는 복합추출물의 나노 리포좀의 온도에 따른 안정성을 측정한 결과이다.
도 4는 본 발명에 따른 Filaggrin 단백질 분석 결과이다.
도 5는 본 발명에 따른 Loricrin(LOR) 단백질 분석 결과이다.
도 6은 본 발명에 따른 TRPV-1 단백질 분석 결과이다.
도 7은 본 발명에 따른 제조예1, 제조예2 에 대한 보습력 및 지속력 보습 평가 결과이다.
도 8은 본 발명에 따른 제조예1, 제조예2 에 대한 경피수분 손실량 개선 평가 결과이다.
도 9는 본 발명에 따른 나노지질담체(NLC)와 통상적인 리포좀의 구성을 비교한 도면이다.Figure 1 is a diagram according to the present invention. The particle diameter size of nano liposomes of a complex extract containing sophoricoside was measured using Photal ELS-Z.
Figure 2 shows the results of measuring the zeta potential using Photal and ELS-Z to measure the stability of nano liposomes of a complex extract containing Sophoricoside according to the present invention.
Figure 3 shows the results of measuring the temperature-dependent stability of nano liposomes of a complex extract containing Sophoricoside according to the present invention.
Figure 4 shows the results of Filaggrin protein analysis according to the present invention.
Figure 5 shows the results of Loricrin (LOR) protein analysis according to the present invention.
Figure 6 shows the results of TRPV-1 protein analysis according to the present invention.
Figure 7 shows the results of moisturizing power and sustained moisturizing power evaluation for Manufacturing Examples 1 and 2 according to the present invention.
Figure 8 shows the results of evaluating the improvement in transepidermal water loss for Manufacturing Examples 1 and 2 according to the present invention.
Figure 9 is a drawing comparing the composition of a nanolipid carrier (NLC) according to the present invention and a conventional liposome.
이하, 시험예 및 실시예를 들어 본 발명에 의한 화장료 조성물에 대하여 상세히 설명하지만, 본 발명이 이들 제조예, 시험예 및 실시예로만 한정되는 것은 아니다. 본 실시예는 당해 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 본 발명을 더욱 상세하게 설명하기 위해서 제공되는 것이다. Hereinafter, the cosmetic composition according to the present invention will be described in detail with reference to test examples and examples, but the present invention is not limited to these manufacturing examples, test examples and examples. These examples are provided to explain the present invention in more detail to a person having ordinary knowledge in the technical field to which the present invention belongs.
본 발명에 따른 복합추출물은 나노 리포좀으로 제조되어 함유되는 것이 특징으로, 나노지질담체(NLC)는 도 9의 (b)에 도시된 바와 같이, 고체 지질 성분(하이드로제네이티드레시틴)과 액체 지질 성분(식물성 오일)으로 구성되어 있으며, 단일막 구조를 갖는다. The complex extract according to the present invention is characterized in that it is manufactured and contained as a nano liposome, and the nano lipid carrier (NLC) is composed of a solid lipid component (hydrogenated lecithin) and a liquid lipid component (vegetable oil), as shown in (b) of FIG. 9, and has a single membrane structure.
이와 같은 본 발명에 따른 나노지질담체(NLC)는 고체 지질과 액체 지질 성분이 함께 존재하기 때문에 피부 표면에 흡착되어 박막 필름을 형성하고 피부를 차폐시키는 효과를 가지고 있다. 즉, 피부로부터 수분의 증발을 물리적으로 차단하여 피부 내 수분을 유지할 수 있다. The nano lipid carrier (NLC) according to the present invention has both solid lipid and liquid lipid components, so it is adsorbed to the skin surface to form a thin film and has a skin shielding effect. In other words, it can physically block evaporation of moisture from the skin and maintain moisture in the skin.
또한, 도 9의 (a),(b)에서 비교되어 도시된 바와 같이, 나노지질담체(NLC)는 고체 지질 성분으로 이루어져 있기 때문에 리포좀보다 물리적 안정성이 뛰어나다는 장점을 가지고 있다. In addition, as shown in comparison in (a) and (b) of FIG. 9, the nanolipid carrier (NLC) has the advantage of superior physical stability compared to liposomes because it is composed of solid lipid components.
특히, 나노지질담체(NLC)는 구조적으로 매우 상이한 지질이 혼합된 구조로 유효성분을 다량 포집할 수 있다.In particular, nanolipid carriers (NLCs) can capture large amounts of active ingredients as a structure in which structurally very different lipids are mixed.
[비교예] 회화나무열매추출물, 건강추출물, 으름덩굴줄기 추출물 제조 [Comparative Example] Manufacturing of Conversation Tree Fruit Extract, Health Extract, and Mugwort Stem Extract
[비교예1: 회화나무열매추출물 추출단계] [Comparative Example 1: Extraction step of the fruit extract of the Chinese juniper tree]
회화나무열매를 50% 에탄올을 이용하여 70℃로 6시간 추출하고, 실온으로 냉각하고, 감압농축 하여 추출물을 얻었다. 얻어진 추출물은 20℃의 서늘한 장소에서 2일간 보관하여 숙성한 후 실험에 사용하였다.The fruit of the conversation tree was extracted with 50% ethanol at 70℃ for 6 hours, cooled to room temperature, and concentrated under reduced pressure to obtain an extract. The obtained extract was stored in a cool place at 20℃ for 2 days to mature, and then used in the experiment.
[비교예2: 건강추출물 추출단계] [Comparative Example 2: Health Extract Extraction Step]
건강을 50% 에탄올을 이용하여 70℃로 6시간 추출하고, 실온으로 냉각하고, 감압농축 하여 추출물을 얻었다. 얻어진 추출물은 20℃의 서늘한 장소에서 2일간 보관하여 숙성한 후 실험에 사용하였다.Health was extracted using 50% ethanol at 70℃ for 6 hours, cooled to room temperature, and concentrated under reduced pressure to obtain an extract. The obtained extract was stored in a cool place at 20℃ for 2 days to mature, and then used in the experiment.
[비교예3: 으름덩굴줄기추출물 추출단계] [Comparative Example 3: Extraction step of the extract of the stem of the vine]
으름덩굴줄기를 50% 에탄올을 이용하여 70℃로 6시간 추출하고, 실온으로 냉각하고, 감압농축 하여 추출물을 얻었다. 얻어진 추출물은 20℃의 서늘한 장소에서 2일간 보관하여 숙성한 후 이용하였다.The stem of the vine was extracted with 50% ethanol at 70℃ for 6 hours, cooled to room temperature, and concentrated under reduced pressure to obtain an extract. The obtained extract was stored in a cool place at 20℃ for 2 days to mature before use.
[감압농축단계][Decompression Concentration Stage]
비교예1, 비교예2, 비교예3의 각 추출단계의 단독으로 추출한 회화나무열매추출물, 건강추출물, 으름덩굴줄기추출물을 냉각하고 감압 농축한다. The extracts of the fruit of the Chinese juniper tree, the health extracts, and the extracts of the stem of the Chinese juniper tree, which were extracted independently in each extraction step of Comparative Examples 1, 2, and 3, were cooled and concentrated under reduced pressure.
보다 구체적으로, 감압농축단계에서는 상기 추출단계의 단독 추출물을 15 ~ 35℃ 실온에서 냉각하고, 감압 농축하는 것이 바람직하다.More specifically, in the reduced pressure concentration step, it is preferable to cool the single extract of the extraction step to room temperature of 15 to 35°C and concentrate it under reduced pressure.
[실시예 1] 복합추출물(회화나무열매, 건강, 으름덩굴줄기)의 제조단계[Example 1] Manufacturing steps of a composite extract (Pine tree fruit, health, and quince stem)
회화나무열매, 건강 및 으름덩굴줄기를 5~10 : 0.5~1 : 0.5~1 의 중량비로 혼합한 혼합물을 50% 에탄올로 70℃에서 6시간 추출을 진행하였다. 추출 진행 후 추출물에 보습제인 다이프로필렌글라이콜과 방부제인 1,2-헥산다이올을 혼합한 다음 실온으로 냉각하여 감압농축을 통해 복합추출물을 확보하였다. 얻어진 추출물은 20℃의 서늘한 장소에서 2일간 보관하여 숙성한 후 실험에 사용하였다.A mixture of the fruits of the conversation tree, health, and vine stems in a weight ratio of 5–10: 0.5–1: 0.5–1 was extracted with 50% ethanol at 70°C for 6 hours. After extraction, the extract was mixed with dipropylene glycol as a moisturizer and 1,2-hexanediol as a preservative, then cooled to room temperature and concentrated under reduced pressure to secure a complex extract. The obtained extract was stored in a cool place at 20°C for 2 days to mature, and then used in the experiment.
[실시예 2] 소포리코시드(Sophoricoside)를 함유하는 복합추출물(회화나무열매, 건강, 으름덩굴줄기)의 나노 리포좀 제조[Example 2] Preparation of nano liposomes from a complex extract (Prunella vulgaris fruit, health, and vine stem) containing sophoricoside
실시예 1의 복합추출물 30중량%를 포함하여 고압유화기를 이용한 나노 리포좀을 제조하였다. 고압미세유화기의 압력 1000 bar, 연속 3회 통과시켰고, 리포좀 조성은 아래 표2와 같이 진행하였다. 고체지질(Solid lipid)성분으로 하이드로제네이티드레시틴(Hydrogenated Lecithin), Cutina®CP(세틸팔미테이트:Cetyl Palmitate)를 사용하고, 액체지질(Liquid lipid)인 식물성 오일로 마카다이아씨오일을 사용하였으며, 유화보조제로 TEGO®Care 450(폴리글리세릴-3메틸글루코오스다이스테아레이트)을 사용하였다.Nano liposomes were manufactured using a high-pressure emulsifier, including 30 wt% of the complex extract of Example 1. The liposome was passed through the high-pressure microemulsifier at a pressure of 1000 bar three times in succession, and the liposome composition was as shown in Table 2 below. Hydrogenated lecithin and Cutina®CP (cetyl palmitate) were used as solid lipid components, macadamia seed oil was used as a liquid lipid (liquid lipid) vegetable oil, and TEGO®Care 450 (polyglyceryl-3 methyl glucose distearate) was used as an emulsifying aid.
여기서, 고체지질(Solid lipid)성분인 하이드로제네이티드레시틴은 인지질 성분 중 하나로, 리포좀 제조시 베지클의 막 형성에 기여한다. Here, hydrogenated lecithin, a solid lipid component, is one of the phospholipid components and contributes to the formation of the vesicle membrane during liposome manufacturing.
(Polyglyceryl-3 Methylglucose Distearate)Polyglyceryl-3 methyl glucose distearate
(Polyglyceryl-3 Methylglucose Distearate)
[실험예 1] 입자 분포의 측정 [Experimental Example 1] Measurement of particle distribution
실시예 1에서 제조된 복합추출물(회화나무열매, 건강, 으름덩굴줄기)이 함유된 나노 리포좀의 입자 분포를 Photal ELS-Z를 이용하여 측정하여 각각 도 1에 나타내었다. The particle distribution of nano liposomes containing the composite extracts (Prunella vulgaris fruit, health, and quince stem) prepared in Example 1 was measured using Photal ELS-Z, and is shown in Figure 1.
도 1에 도시된 바와 같이, 측정 결과 복합추출물(회화나무열매, 건강, 으름덩굴줄기) 함유 나노 리포좀의 평균 입자 크기가 각각 139.2 nm 임을 알 수 있었다.As shown in Figure 1, the measurement results showed that the average particle size of the nano liposomes containing the composite extracts (Prunella vulgaris fruit, health, and quince stem) was 139.2 nm, respectively.
[실험예 2] 제타 전위(zeta potential) 측정[Experimental Example 2] Measurement of zeta potential
실시예 2에서 제조된 Sophoricoside를 함유하는 복합추출물(회화나무열매, 건강, 으름덩굴줄기)의 나노 리포좀의 안정성 측정을 위해 제타포텐셜을 Photal, ELS-Z 를 이용하여 측정하여 그 결과를 도 2에 나타내었다. In order to measure the stability of nano liposomes of the complex extract (Prunella vulgaris fruit, health, and quince stem) containing sophoricoside prepared in Example 2, the zeta potential was measured using Photal and ELS-Z, and the results are shown in Fig. 2.
도 2에 도시된 바와 같이, 측정 결과 전위가 -16.87 mV로 안정함으로 알 수 있었다.As shown in Fig. 2, the measurement result showed that the potential was stable at -16.87 mV.
[실험예 3] Turbiscan을 이용한 안정도 측정[Experimental Example 3] Stability Measurement Using Turbiscan
실시예 2에서 제조된 Sophoricoside를 함유하는 복합추출물(회화나무열매, 건강, 으름덩굴줄기)의 안정도를 측정하기 위해 Turbiscan(TurbiscanLAB, Formulaction, France)을 이용하여 리포좀 원물 시료의 윗부분부터 바닥까지 4시간 동안 45℃, 25℃ 두가지 조건에서 근적외선을 50번 조사하였다. 이를 통해 형성된 나노 리포좀의 분산안정성과 입자크기를 확인하였고, 그 결과를 도 3에 나타내었다. In order to measure the stability of the complex extract (Prunella vulgaris fruit, health, and quince stem) containing Sophoricoside manufactured in Example 2, near-infrared rays were irradiated 50 times under two conditions of 45℃ and 25℃ for 4 hours from the top to the bottom of the liposome raw sample using Turbiscan (TurbiscanLAB, Formulation, France). The dispersion stability and particle size of the formed nanoliposomes were confirmed, and the results are shown in Fig. 3.
도 3에 도시된 바와 같이, 측정결과 그래프의 큰 변화 없이 일정한 것으로 나타났으며, 안정한 물성임을 확인하였다. As shown in Figure 3, the measurement results graph showed no significant change and was constant, confirming that it was a stable material property.
[실험예 4] 복합추출물(회화나무열매, 건강, 으름덩굴줄기)을 유효성분으로 포함하는 나노리포좀 경피흡수율 측정 [Experimental Example 4] Measurement of the percutaneous absorption rate of nanoliposomes containing composite extracts (Prunella vulgaris fruit, health, and quince stem) as active ingredients
실시예 1과 실시예 2 제조 원료의 Sophoricoside의 피부 침투율을 비교 평가 하였다. 인공피부인 Strat-M®Membrane (Transdermal Diffusion Test Model)을 사용하여 Franz-type diffusion cell(Transdermal Semi-Auto Diffusion Cell, LOGAN Instruments, USA)에 장착하여 실험하였다. The skin penetration rate of Sophoricoside of the raw materials manufactured in Examples 1 and 2 was compared and evaluated. The experiment was conducted by mounting it on a Franz-type diffusion cell (Transdermal Semi-Auto Diffusion Cell, LOGAN Instruments, USA) using an artificial skin, Strat-M®Membrane (Transdermal Diffusion Test Model).
Franz-type diffusion cell의 Receptor용기(5mL)에 50 mM 인산염 완충액(pH 7.4, 0.1M NaCl)을 넣어준 후, diffusion cell을 32℃, 600 rpm으로 혼합, 분산시켜 주었으며, 실시예 1와 실시예 2 샘플을 donor용기에 넣어 주었다. After adding 50 mM phosphate buffer (pH 7.4, 0.1 M NaCl) to the receptor container (5 mL) of the Franz-type diffusion cell, the diffusion cell was mixed and dispersed at 32°C and 600 rpm, and the samples of Example 1 and Example 2 were placed in the donor container.
Franz diffusion cell 과 Media 사이에 인공피부를 넣고 고정시킨 뒤, 48시간 동안 흡수 경과를 지켜본 후, 고정된 주사기로 media 용액을 모두 회수하였다. After placing and fixing the artificial skin between the Franz diffusion cell and the media, the absorption process was observed for 48 hours, and then all of the media solution was recovered using a fixed syringe.
HPLC 분석을 통해 회수한 media 용액 내에 포함되어 있는 Sophoricoside 함량을 정량적으로 평가하였다.The content of Sophoricoside contained in the recovered media solution was quantitatively evaluated through HPLC analysis.
[실험예 4-1] Sophoricoside HPLC 함량 분석[Experimental Example 4-1] Sophoricoside HPLC content analysis
실시예 1, 2에서 제조된 나노 리포좀에 함유된 Sophoricoside의 함량을 측정하기 위하여 아래 표 3의 조건의 HPLC (Model 510 Waters USA) 분석 방법을 이용하였다. To measure the content of Sophoricoside contained in the nano liposomes manufactured in Examples 1 and 2, an HPLC (Model 510 Waters USA) analysis method was used under the conditions in Table 3 below.
측정결과는 도 4에 나타내었으며, 도 4에 도시된 바와 같이, 실시예 1은 초기 함량 분석 값 (0hr) 약 1.15%에서 경피 흡수 후 (24hrs) 약 0.00014%로 검출되었고, 흡수량은 약 0.012%로 확인되었다.The measurement results are shown in Fig. 4, and as illustrated in Fig. 4, Example 1 was detected from about 1.15% in the initial content analysis value (0 hr) to about 0.00014% after percutaneous absorption (24 hrs), and the absorption amount was confirmed to be about 0.012%.
실시예 2는 초기 함량 분석 값 (0hr) 약 0.313%에서 경피 흡수 후 (24hrs), 약 0.00093%로 검출되었고, 흡수량은 약 0.30%로 확인되었다.Example 2 was detected at about 0.313% in the initial content analysis value (0 hr) and about 0.00093% after percutaneous absorption (24 hrs), and the absorption amount was confirmed to be about 0.30%.
실시예 2의 나노 리포좀의 경피흡수량이 약 20 배 정도 높은 피부 흡수율을 보였다. The nano liposome of Example 2 showed a skin absorption rate that was approximately 20 times higher than the percutaneous absorption rate.
[실험예 5] 인공피부에서 Histamine 자극에 의한 가려움 개선 효능 시험 [Experimental Example 5] Test for Itching Improvement Efficacy by Histamine Stimulation in Artificial Skin
Reconstructed skin tissue에서 Histamine에 의해 유도되는 소양감과 관련된 단백질인 Filaggrin, Loricrin 및 Transient receptor potential vanilloid type 1(TRPV-1)에 미치는 영향에 대한 시험을 진행하였다. 실험방법은 Reconstructed skin tissue에 48시간마다 시료 및 자극 물질(histamine)을 처리하고, 5일 뒤 조직을 회수하여 조직을 10% Neutral Buffered formalin에 24시간 고정한다. OCT Compound로 포매하여 12μm 절편을 만든 뒤 슬라이드에 고정한다.We conducted a test on the effects of histamine-induced itching-related proteins, Filaggrin, Loricrin, and Transient receptor potential vanilloid type 1 (TRPV-1), in reconstructed skin tissue. The experimental method is to treat the reconstructed skin tissue with samples and irritants (histamine) every 48 hours, harvest the tissue after 5 days, and fix it in 10% Neutral Buffered formalin for 24 hours. Embed it with OCT Compound, make 12 μm sections, and then fix it on slides.
H&E (Hematoxylin and eosin) 염색을 진행한 후, 현미경 상에서 General Morphology를 관찰한다. 면역형광염색 (Immunofluorescence staining)을 진행한 후 형광 현미경 상에서 관찰한다. After performing H&E (Hematoxylin and eosin) staining, observe General Morphology under a microscope. After performing immunofluorescence staining, observe under a fluorescence microscope.
(1) Filaggrin(FLG) 단백질 분석 결과(1) Results of Filaggrin (FLG) protein analysis
Filaggrin(FLG)은 표피에서 각질층의 형성에 중요한 역할을 하는 단백질이다. Filaggrin의 증가는 정상적인 피부장벽을 형성하여 피부 수분증발을 막는 것을 의미한다. Filaggrin은 표피의 과립층부터 각질층 부분까지 붉은색 형광을 띠며 염색되었다. 푸른빛은 세포의 핵을 염색한 것이다.Filaggrin (FLG) is a protein that plays an important role in the formation of the stratum corneum in the epidermis. An increase in filaggrin means that a normal skin barrier is formed, preventing skin moisture evaporation. Filaggrin was stained with red fluorescence from the granular layer of the epidermis to the stratum corneum. The blue light is the staining of the cell nucleus.
측정 결과, Histamine 10μM처리군과 비교하여 실시예 1 처리시 통계적으로 유의한 변화가 있었으며, 증가율은 321.93% 였다. As a result of the measurement, there was a statistically significant change in the Example 1 treatment group compared to the Histamine 10 μM treatment group, and the increase rate was 321.93%.
Histamine 10μM 처리군과 비교하여 실시예 2 처리시 통계적으로 유의한 변화가 있었으며, 증가율은 442.58% 였다. Compared to the histamine 10 μM treatment group, there was a statistically significant change in the Example 2 treatment, and the increase rate was 442.58%.
이는 시험시료에 의해 FLG 양이 증가 되었음을 나타낸다.This indicates that the amount of FLG was increased by the test sample.
(2) Loricrin(LOR) 단백질 분석 결과(2) Results of Loricrin (LOR) protein analysis
Loricrin(LOR) 은 각질형성세포가 최종 분화를 거치는 동안 발현되는 단백질로서, 각질형성세포가 분화하여 안정적인 각질을 형성하는데 필요하며 각질 질량의 70~85%를 차지하는 물질인데, 이는 트랜스글루타미나제가 촉매하는 펩티드간의 교차 결합에 참여할 수 있는 글루타민과 리신이 풍부한 도메인을 가지고 있으며, 각질 형성 단백질들간의 교차 결합을 도와줌으로써 각질형성에 중요한 역할을 수행한다. 이 단백질은 Histamine 에 지속적으로 노출된 피부에서 발현이 감소된다. Loricrin (LOR) is a protein expressed during the terminal differentiation of keratinocytes. It is necessary for keratinocytes to differentiate and form stable keratin and accounts for 70-85% of keratin mass. It has a domain rich in glutamine and lysine that can participate in cross-linking between peptides catalyzed by transglutaminase, and plays an important role in keratinogenesis by helping cross-linking between keratinogenic proteins. The expression of this protein is reduced in skin continuously exposed to histamine.
측정 결과, Histamine 10μM 처리군과 비교하여 실시예 1 처리 시 통계적으로 유의한 변화가 있었으며, 증가율은 154.74% 였다. The measurement results showed that there was a statistically significant change in the Example 1 treatment group compared to the Histamine 10 μM treatment group, and the increase rate was 154.74%.
Histamine 10μM 처리군과 비교하여 실시예 2 처리시 통계적으로 유의한 변화가 있었으며, 증가율은 188.14% 였다. Compared to the histamine 10 μM treatment group, there was a statistically significant change in the Example 2 treatment, and the increase rate was 188.14%.
이는 시험시료에 의해 LOR 양이 증가 되었음을 나타낸다.This indicates that the amount of LOR was increased by the test sample.
(3) TRPV-1 단백질 분석 결과 (3) Results of TRPV-1 protein analysis
TRP 채널 중에서 캡사이신 수용체로 알려진 TRPV-1 (transient receptor potential vanilloid type 1)은 화끈거리는 열 통각 유발 외에 외부자극에 대해 반응하여 스스로를 보호하는 역할을 한다. TRPV1이 과도하게 활성화될 경우 열감, 가려움이 증가하여 피부에 민감함이 유발 된다. 이는 히스타민에 의하여 과도하게 활성화 된다. Among the TRP channels, TRPV-1 (transient receptor potential vanilloid type 1), known as the capsaicin receptor, plays a role in protecting oneself by responding to external stimuli in addition to causing a burning sensation of heat. When TRPV1 is excessively activated, it increases the sensation of heat and itchiness, causing skin sensitivity. This is excessively activated by histamine.
측정결과, Histamine 10μM 처리군과 비교하여 실시예 1 처리 시 통계적으로 유의한 변화가 있었으며, 증가율은 56.17% 였다. The measurement results showed that there was a statistically significant change in the Example 1 treatment group compared to the Histamine 10 μM treatment group, and the increase rate was 56.17%.
Histamine 10μM 처리군과 비교하여 실시예 2 처리시 통계적으로 유의한 변화가 있었으며, 증가율은 69.74% 였다. Compared to the histamine 10 μM treatment group, there was a statistically significant change in the Example 2 treatment, and the increase rate was 69.74%.
이는 시험시료에 의해 TRPV-1 양이 증가 되었음을 나타낸다.This indicates that the amount of TRPV-1 was increased by the test sample.
[실험예 6] 피부자극에 대한 일차피부자극 시험 [Experimental Example 6] Primary skin irritation test for skin irritation
상기 실시예 1, 2 에서 제조한 복합추출물을 아래 제조예 1, 제조예 2의 내용대로 제조한 크림을 이용하여 건강한 성인 남녀 30명을 대상으로 인체 피부 자극에 대한 효과 시험을 다음과 같이 수행하였다.The complex extracts manufactured in Examples 1 and 2 above were used to prepare a cream according to the contents of Manufacturing Examples 1 and 2 below, and the following test was conducted on the skin irritation effect of 30 healthy adult men and women.
[제조예 1] 실시예1의 회화나무열매, 건강, 으름덩굴줄기 복합추출물을 적용한 크림 제조 [Manufacturing Example 1] Manufacturing of a cream using the combined extracts of the fruit of the Chinese juniper tree, health, and the stem of the Chinese juniper tree of Example 1
세테아릴올리베이트, 솔비탄올리베이트, 세테아릴알코올, 하이드로제네이티드폴리데센, 스쿠알란을 75℃ 내지 80℃로 가열 용해하여 투명 유화계를 제조하였다. 다이소듐이디티에이, 글리세린, 판테놀, 카보머를 정제수에 분산시켜 70℃ 내지 75℃ 로 가열한 수상에 용해된 유화계를 첨가한 후 호모믹서로 3500rpm 내지 4000rpm 조건 하에서 5분간 유화하였다. 60℃ 내지 65℃에서 트로메타민을 첨가한 후 호모 믹서로 3000rpm 내지 3500rpm 조건 하에서 3분간 교반하여 중화하였다. 45℃에서 1,2-헥산다이올, 에틸헥실글리세린을 투입하고 3분간 교반한 후 30℃까지 냉각하였다. 그 후 CSP-811을 투입하고 3분간 교반 및 탈포하여 크림 제형을 제조하였다.A transparent emulsifying system was prepared by dissolving cetearyl olivate, sorbitan olivate, cetearyl alcohol, hydrogenated polydecene, and squalane at 75°C to 80°C. Disodium EDTA, glycerin, panthenol, and carbomer were dispersed in purified water, and the emulsifying system dissolved in the water phase heated to 70°C to 75°C was added, and emulsified for 5 minutes under the conditions of 3,500 to 4,000 rpm with a homomixer. Tromethamine was added at 60°C to 65°C, and the mixture was stirred for 3 minutes under the conditions of 3,000 to 3,500 rpm with a homomixer to neutralize. 1,2-hexanediol and ethylhexylglycerin were added at 45°C, stirred for 3 minutes, and then cooled to 30°C. After that, CSP-811 was added and stirred and defoamed for 3 minutes to prepare a cream formulation.
[제조예 2] 실시예2의 회화나무열매, 건강, 으름덩굴줄기 복합추출물의 나노 리포좀을 적용한 크림 제조 [Manufacturing Example 2] Manufacturing of a cream using nano liposomes of the combined extracts of the fruit of the Chinese juniper tree, health, and the stem of the Chinese juniper tree of Example 2
세테아릴올리베이트, 솔비탄올리베이트, 세테아릴알코올, 하이드로제네이티드폴리데센, 스쿠알란을 75℃ 내지 80℃로 가열 용해하여 투명 유화계를 제조하였다. 다이소듐이디티에이, 글리세린, 판테놀, 카보머를 정제수에 분산시켜 70℃ 내지 75℃ 로 가열한 수상에 용해된 유화계를 첨가한 후 호모믹서로 3500rpm 내지 4000rpm 조건 하에서 5분간 유화하였다. 60℃ 내지 65℃에서 트로메타민을 첨가한 후 호모 믹서로 3000rpm 내지 3500rpm 조건 하에서 3분간 교반하여 중화하였다. 45℃에서 1,2-헥산다이올, 에틸헥실글리세린을 투입하고 3분간 교반한 후 30℃까지 냉각하였다. 그 후 CSP-811 나노 리포좀을 투입하고 3분간 교반 및 탈포하여 크림 제형을 제조하였다.A transparent emulsifying system was prepared by dissolving cetearyl olivate, sorbitan olivate, cetearyl alcohol, hydrogenated polydecene, and squalane at 75°C to 80°C. Disodium EDTA, glycerin, panthenol, and carbomer were dispersed in purified water, and the emulsifying system dissolved in the water phase heated to 70°C to 75°C was added, and emulsified for 5 minutes under the conditions of 3,500 to 4,000 rpm with a homomixer. Tromethamine was added at 60°C to 65°C, and the mixture was stirred for 3 minutes under the conditions of 3,000 to 3,500 rpm with a homomixer to neutralize. 1,2-hexanediol and ethylhexylglycerin were added at 45°C, stirred for 3 minutes, and then cooled to 30°C. After that, CSP-811 nano liposomes were added and stirred and defoamed for 3 minutes to prepare a cream formulation.
시험 부위는 피실험자의 등 부위를 실시하였고, 측정조건을 동일하게 하고자 시험부위를 깨끗하고 마른 상태로 유지 하였으며, 최소 30분간 항온항습(22±2℃, R.H. 40~60%)이 유지되는 곳에서 피부 안정을 취한 후 진행하였다. The test area was the subject's back, and to ensure the same measurement conditions, the test area was kept clean and dry. The test was performed after allowing the skin to rest in a place with constant temperature and humidity (22±2℃, R.H. 40-60%) for at least 30 minutes.
제조예 1, 제조예 2를 24시간 동안 피부에 첩포하였으며, 첩포를 제거하고 30분, 24시간, 48시간이 경과된 후에 시험부위에서 나타난 피부반응을 국제접촉피부염 연구회 (International Contact Dermatitis Research Group: ICDRG)의 판정기준에 따라 자극정도를 분류하고, 피부 첩포시험 (Patch Test) 결과 판정표에 따라 평균 피부반응도 (Mean score)를 구하였다. Manufacturing Examples 1 and 2 were applied to the skin as patches for 24 hours, and after the patches were removed, skin reactions appearing at the test site were classified into the degree of irritation according to the criteria of the International Contact Dermatitis Research Group (ICDRG), and the average skin reaction score was calculated according to the skin patch test result assessment table.
실험결과, 도 5에 나타낸 바와 같이, 제조예 1, 제조예 2는 24시간, 48시간 모두에서 자극이 관찰되지 않았다. 평균 피부반응도는 0.00으로 무자극으로 판정하였다. As a result of the experiment, as shown in Fig. 5, no irritation was observed for Manufacturing Examples 1 and 2 for 24 hours and 48 hours. The average skin reactivity was 0.00, which was judged as non-irritating.
[실험예 7] 보습력 및 지속 보습력 평가 [Experimental Example 7] Evaluation of moisturizing power and continuous moisturizing power
준비 단계에서 피험자들의 측정 조건을 동일하게 하고자 시험 부위를 깨끗하고 마른 상태로 유지하였으며 최소 30분간 항온항습 (22±2℃ R.H. 40~60%)이 유지되는 곳에서 피부 안정을 취한 후 진행하였다. 측정 단계에서 제조예1, 제조예2 제품을 전완부의 선정된 시험부위(5cm X 4cm)에 Micro pipette을 사용하여 2mg/cm2 의 양으로 도포하였다. 측정은 제품 사용 전, 사용 후, 3시간 후, 6시간 후로 총 4회 측정하며 3개의 값을 이용해 평균값을 구하였다. 피부 수분 측정은 aphrodite moisture checker MC-1000를 이용하여 측정하였다.In the preparation stage, the test area was kept clean and dry to ensure the same measurement conditions for the subjects, and the skin was allowed to rest in a place with constant temperature and humidity (22±2℃ RH 40~60%) for at least 30 minutes before testing. In the measurement stage, the products of Manufacturing Examples 1 and 2 were applied to the selected test area (5 cm X 4 cm) of the forearm using a micro pipette in an amount of 2 mg/ cm2 . The measurements were taken four times in total, before, after, 3 hours later, and 6 hours later, and the average value was calculated using the three values. Skin moisture was measured using an aphrodite moisture checker MC-1000.
보습 및 보습 지속력을 평가한 결과, 제조예1은 도포 후 52.5%, 도포 3시간 후 49.5%, 도포 6시간 후 44.8% 보습력이 증가하며 유지되는 것으로 나타났다. 제조예2는 도포 후 58.0%, 도포 3시간 후 55.8%, 도포 6시간 후 48.4% 보습력이 증가하며 유지되는 것으로 나타났다.As a result of evaluating moisturizing and moisturizing durability, Manufacturing Example 1 showed an increase and maintenance of moisturizing power of 52.5% after application, 49.5% after 3 hours of application, and 44.8% after 6 hours of application. Manufacturing Example 2 showed an increase and maintenance of moisturizing power of 58.0% after application, 55.8% after 3 hours of application, and 48.4% after 6 hours of application.
[실험예 8] 피부 수분손실량 개선 평가 [Experimental Example 8] Evaluation of improvement in skin moisture loss
준비 단계에서 피험자들의 측정 조건을 동일하게 하고자 시험 부위를 깨끗하고 마른 상태로 유지하였으며 최소 30분간 항온항습 (22±2℃ R.H. 40~60%)이 유지되는 곳에서 피부 안정을 취한 후 진행하였다. 측정 단계에서 제조예 1, 제조예 2 제품을 전완부의 선정된 시험부위(5cm X 4cm)에 Micro pipette을 사용하여 2mg/cm2 의 양으로 도포하였다. 측정은 제품 사용 전, 3시간 후 총 2회 측정하며 3개의 값을 이용해 평균값을 구하였다. 경피수분손실량 측정은 Tewameter®TM 300 기기를 이용하여 측정하였다.In the preparation stage, the test area was kept clean and dry to ensure the same measurement conditions for the subjects, and the skin was allowed to rest in a place with constant temperature and humidity (22±2℃ RH 40~60%) for at least 30 minutes before the test. In the measurement stage, the products of Manufacturing Examples 1 and 2 were applied to the selected test area (5 cm X 4 cm) on the forearm using a micro pipette at an amount of 2 mg/ cm2 . Measurements were taken twice in total, before and after 3 hours of product use, and the average value was calculated using the three values. The transepidermal water loss was measured using a Tewameter®TM 300 device.
경피수분손실량 개선을 평가한 결과, 제조예1은 도포 후 58.1% 개선되었으며, 도포 3시간 후 48.7%, 도포 6시간 후 41.3% 개선되며 지속적인 효과가 나타났다. 제조예 2는 도포 후 31.8% 개선되었으며, 도포 3시간 후 32.3%, 도포 6시간 후 46.4% 개선되며 지속적인 개선효과가 나타났다. As a result of evaluating the improvement in transepidermal water loss, Manufacturing Example 1 showed a 58.1% improvement after application, a 48.7% improvement after 3 hours, and a 41.3% improvement after 6 hours, demonstrating a continuous effect. Manufacturing Example 2 showed a 31.8% improvement after application, a 32.3% improvement after 3 hours, and a 46.4% improvement after 6 hours, demonstrating a continuous effect of improvement.
앞에서 설명된 본 발명의 실시예는 본 발명의 기술적 사상을 한정하는 것으로 해석되어서는 안된다. 본 발명의 보호범위는 청구범위에 기재된 사항에 의하여만 제한되고, 본 발명의 기술 분야에서 통상의 지식을 가진 자는 본 발명의 기술적 사상을 다양한 형태로 개량 변경하는 것이 가능하다. 따라서, 이러한 개량 및 변경은 통상의 지식을 가진 자에게 자명한 것인 한 본 발명의 보호범위에 속하게 될 것이다. The embodiments of the present invention described above should not be construed as limiting the technical idea of the present invention. The protection scope of the present invention is limited only by the matters described in the claims, and those with ordinary knowledge in the technical field of the present invention can improve and change the technical idea of the present invention in various forms. Accordingly, such improvements and changes will fall within the protection scope of the present invention as long as they are obvious to those with ordinary knowledge.
Claims (9)
상기 복합추출물은 나노 리포좀으로 제조되어 함유되는 것을 특징으로 하는 가려움 개선용 화장료 조성물.
Contains a complex extract extracted by mixing the fruits of the conversation tree, health and the stem of the vine,
A cosmetic composition for improving itching, characterized in that the above complex extract is manufactured and contained in the form of nano liposomes.
상기 복합추출물의 회화나무열매, 건강 및 으름덩굴줄기는, 5~10 : 0.5~1 : 0.5~1의 중량비로 혼합되는 것을 특징으로 하는 가려움 개선용 화장료 조성물.
In paragraph 1,
A cosmetic composition for improving itching, characterized in that the fruits of the above-mentioned compound extract, the health extract, and the stem of the mugwort are mixed in a weight ratio of 5 to 10: 0.5 to 1: 0.5 to 1.
상기 복합추출물은 소포리코시드(Sophoricoside)를 함유하는 것을 특징으로 하는 가려움 개선용 화장료 조성물.
In paragraph 1 or 2,
A cosmetic composition for improving itching, characterized in that the above complex extract contains sophoricoside.
상기 제1 단계의 혼합물을 에탄올로 추출하는 제2 단계;
상기 제2 단계의 추출 진행 후 냉각하여 감압농축을 통해 복합추출물을 얻는 제3 단계; 및
상기 제3 단계로 얻은 복합추출물을 숙성시키는 제4 단계;를 포함하여 제조된 복합추출물을 함유하며,
상기 제조된 복합추출물을 고체지질과 액체지질, 및 유화보조제와 함께 고압미세유화기를 통과시켜 나노 리포좀으로 제조하는 것을 특징으로 하는 가려움 개선용 화장료 조성물 제조방법.
Step 1: Making a mixture by mixing the fruits of the conversation tree, health and the vine;
A second step of extracting the mixture of the first step with ethanol;
A third step of obtaining a complex extract through cooling and depressurization concentration after the extraction in the second step; and
A fourth step of maturing the complex extract obtained in the third step; containing the manufactured complex extract,
A method for producing a cosmetic composition for improving itching, characterized in that the above-mentioned manufactured complex extract is passed through a high-pressure microemulsifier together with a solid lipid, a liquid lipid, and an emulsifying agent to produce nano liposomes.
상기 제1 단계의 회화나무열매, 건강 및 으름덩굴줄기는, 5~10 : 0.5~1 : 0.5~1 의 중량비로 혼합되는 것을 특징으로 하는 가려움 개선용 화장료 조성물 제조방법.
In paragraph 4,
A method for producing a cosmetic composition for improving itching, characterized in that the first step conversation tree fruit, health and mugwort vine are mixed in a weight ratio of 5 to 10: 0.5 to 1: 0.5 to 1.
상기 제1 단계에는 보습제와 방부제가 포함되고,
상기 보습제는 다이프로필렌글라이콜이고, 상기 방부제는 1,2-헥산다이올인 것을 특징으로 하는 가려움 개선용 화장료 조성물 제조방법.
In paragraph 4,
The first step above includes moisturizers and preservatives,
A method for producing a cosmetic composition for improving itching, characterized in that the moisturizer is dipropylene glycol and the preservative is 1,2-hexanediol.
상기 제조된 복합추출물은 소포리코시드(Sophoricoside)를 함유하는 것을 특징으로 하는 가려움 개선용 화장료 조성물 제조방법.
In paragraph 4,
A method for producing a cosmetic composition for improving itching, characterized in that the above-mentioned manufactured complex extract contains sophoricoside.
상기 고체지질은 하이드로제네이티드레시틴, 세틸팔미테이트로 이루어진 군에서 선택된 1이상이며,
상기 액체지질은 마카다미아씨오일이며,
상기 유화보조제는 폴리글리세릴-3메틸글루코오스다이스테아레이트인 것을 특징으로 하는 가려움 개선용 화장료 조성물 제조방법.
In paragraph 4,
The above solid lipid is at least one selected from the group consisting of hydrogenated lecithin and cetyl palmitate,
The above liquid lipid is macadamia seed oil.
A method for producing a cosmetic composition for improving itching, characterized in that the emulsifying agent is polyglyceryl-3 methyl glucose distearate.
상기 복합추출물은 화장료 조성물 총 중량 대비 30~35 중량% 함유되는 것을 특징으로 하는 가려움 개선용 화장료 조성물 제조방법.In paragraph 4,
A method for producing a cosmetic composition for improving itching, characterized in that the above complex extract is contained in an amount of 30 to 35 wt% based on the total weight of the cosmetic composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020230189108A KR20250099473A (en) | 2023-12-22 | 2023-12-22 | Cosmetic composition for improving skin itching comprising the complex extract of sophora japonica fruits, dried ginger and akebiae quinata caulis, and manufacturing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020230189108A KR20250099473A (en) | 2023-12-22 | 2023-12-22 | Cosmetic composition for improving skin itching comprising the complex extract of sophora japonica fruits, dried ginger and akebiae quinata caulis, and manufacturing method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20250099473A true KR20250099473A (en) | 2025-07-02 |
Family
ID=96391350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020230189108A Pending KR20250099473A (en) | 2023-12-22 | 2023-12-22 | Cosmetic composition for improving skin itching comprising the complex extract of sophora japonica fruits, dried ginger and akebiae quinata caulis, and manufacturing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20250099473A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140071716A (en) | 2012-12-04 | 2014-06-12 | 주식회사 코리아나화장품 | Cosmetic composition comprising the extract of Akebia quinata as active ingredi ent |
| KR102121457B1 (en) | 2017-12-26 | 2020-06-10 | 주식회사 단정바이오 | Cosmetic composition comprising the extract of fermented Sophora Japonica Fruits for skin anti-wrinkle effect and producing method thereof |
| KR102232341B1 (en) | 2019-02-12 | 2021-03-26 | 우석대학교 산학협력단 | Cosmetic composition for preventing or improving skin aging or skin inflammation comprising fermented product of Mentha piperascens leaf and ginger as an active ingredient |
| KR102579345B1 (en) | 2023-04-11 | 2023-09-21 | 한국콜마주식회사 | Cosmetic composition comprising protein derived from sophpra japonica flower |
-
2023
- 2023-12-22 KR KR1020230189108A patent/KR20250099473A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140071716A (en) | 2012-12-04 | 2014-06-12 | 주식회사 코리아나화장품 | Cosmetic composition comprising the extract of Akebia quinata as active ingredi ent |
| KR102121457B1 (en) | 2017-12-26 | 2020-06-10 | 주식회사 단정바이오 | Cosmetic composition comprising the extract of fermented Sophora Japonica Fruits for skin anti-wrinkle effect and producing method thereof |
| KR102232341B1 (en) | 2019-02-12 | 2021-03-26 | 우석대학교 산학협력단 | Cosmetic composition for preventing or improving skin aging or skin inflammation comprising fermented product of Mentha piperascens leaf and ginger as an active ingredient |
| KR102579345B1 (en) | 2023-04-11 | 2023-09-21 | 한국콜마주식회사 | Cosmetic composition comprising protein derived from sophpra japonica flower |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101584742B1 (en) | Cosmetic composition for improving skin-aging | |
| US8906433B2 (en) | Cosmetic composition for skin moisturisation comprising pine-resin extract, Pinus densiflora needle extract and Pinus densiflora root extract | |
| KR101425031B1 (en) | Cosmetic composition for anti-irritation and skin moisturization containing Citrus junos Siebold seed oil and Mangifera Indica seed oil | |
| KR20100029057A (en) | Cosmetic or dermatological compositions comprising a mixture of essential oils, and its uses thereof, particularly for the care of sensitive or sensitized skin | |
| KR20170103172A (en) | Cosmetic compositions containing centella asiatica extract, ceramide and betula alba juice for relieving skin irritation and reinforcing skin barrier | |
| KR101736714B1 (en) | Cosmetic composition for improvement of skin function comprising natural extract | |
| KR20230152511A (en) | Cosmetic composition in relieving skin for skin regenerating, Manufacturing method thereof, and Cosmetics containing the same | |
| KR20130045451A (en) | Cosmetic composition containing croton lechleri resin extract | |
| KR101017586B1 (en) | Cosmetic composition for skin whitening | |
| KR101056756B1 (en) | Cosmetic composition containing herbal extract | |
| KR101934976B1 (en) | Composition for enhancing skin barrier comprising mixture of Diospyros lotus leaf extract and Curcuma longa extract as effective component | |
| KR102162377B1 (en) | Extracts derived from natural products and cosmetic composition containing the same, and process for producing the same | |
| KR101760190B1 (en) | Cosmetic composition for anti-stretch mark effect on the skin containing ginger extract | |
| KR20250099473A (en) | Cosmetic composition for improving skin itching comprising the complex extract of sophora japonica fruits, dried ginger and akebiae quinata caulis, and manufacturing method thereof | |
| KR20110089793A (en) | Cosmetic composition | |
| KR100834484B1 (en) | Oil Type Cosmetic Composition Containing Cereals, a Plant Mixture Extract | |
| KR20200108207A (en) | A method for extracting fat soluble solvent of Loquat leaf (Eriobotrya japonica Lindley) and Taraxaci Herba(Taraxacum platycarpum) for use as a cosmetic composition | |
| KR20120001161A (en) | Skin moisturizing composition comprising the extract obtained by the enzyme treatment | |
| KR102541771B1 (en) | Cosmetic Composition For Moisturizing Skin Comprising Mixed Extracts of Chaenomeles sinensis fruit, Diospyros kaki leaf, Cinnamomum cassia bark, Artemisia princeps leaf, Chrysanthellum indicum and Camellia sinensis leaf as Active Ingredient | |
| KR102782317B1 (en) | Cosmetic composition having an atopic improvement effect | |
| CN119925242B (en) | Crack-resistant repairing composition containing sweet wormwood herb and camellia seed oil and preparation and application thereof | |
| CN119770406B (en) | External repairing anti-wrinkle composition and preparation method thereof | |
| CN115969759B (en) | Photoprotective plant extract compositions and uses thereof | |
| KR100702176B1 (en) | Low irritant cosmetic composition | |
| KR20130104261A (en) | Cosmetic composition for moisturizing effect on the skin containing the mixture of citron seed extract, seaweed extract and linseed extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| D13-X000 | Search requested |
St.27 status event code: A-1-2-D10-D13-srh-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |